117 related articles for article (PubMed ID: 12472285)
61. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
62. Small-cell tumors of the liver: a cytological study of 91 cases and a review of the literature.
Khalbuss WE; Grigorian S; Bui MM; Elhosseiny A
Diagn Cytopathol; 2005 Jul; 33(1):8-14. PubMed ID: 15945087
[TBL] [Abstract][Full Text] [Related]
63. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract][Full Text] [Related]
64. Reduced expression of TANGO in colon and hepatocellular carcinomas.
Arndt S; Bosserhoff AK
Oncol Rep; 2007 Oct; 18(4):885-91. PubMed ID: 17786351
[TBL] [Abstract][Full Text] [Related]
65. Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma: a systemic immunohistochemical survey using tissue array technique.
Pan CC; Chen PC; Tsay SH; Ho DM
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):347-52. PubMed ID: 16280664
[TBL] [Abstract][Full Text] [Related]
66. Diagnostic utility of CDX-2 expression in separating metastatic gastrointestinal adenocarcinoma from other metastatic adenocarcinoma in fine-needle aspiration cytology using cell blocks.
Saad RS; Essig DL; Silverman JF; Liu Y
Cancer; 2004 Jun; 102(3):168-73. PubMed ID: 15211476
[TBL] [Abstract][Full Text] [Related]
67. [Histological atlas of brain tumors (12): Metastatic brain tumors].
Nomura K
No Shinkei Geka; 1990 May; 18(5):407-11. PubMed ID: 2166919
[No Abstract] [Full Text] [Related]
68. Erythropoietin immunolocalization in renal cell carcinoma.
Clark D; Kersting R; Rojiani AM
Mod Pathol; 1998 Jan; 11(1):24-8. PubMed ID: 9556419
[TBL] [Abstract][Full Text] [Related]
69. Hepatocyte expressions in hepatocellular carcinomas, gastrointestinal neoplasms, and non-neoplastic gastrointestinal mucosa: its role as a diagnostic marker.
Lee HS; Kim WH; Kang GH
J Korean Med Sci; 2003 Dec; 18(6):842-8. PubMed ID: 14676441
[TBL] [Abstract][Full Text] [Related]
70. MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers.
Proca DM; Niemann TH; Porcell AI; DeYoung BR
Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):120-5. PubMed ID: 10937059
[TBL] [Abstract][Full Text] [Related]
71. BCA-225 immunostain: is it of value in liver fine needle aspiration?
Williams SS; Zimmerman RL; Bibbo M
Anal Quant Cytol Histol; 2002 Oct; 24(5):245-8. PubMed ID: 12408555
[TBL] [Abstract][Full Text] [Related]
72. Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration.
Zimmerman RL; Burke M; Young NA; Solomides CC; Bibbo M
Cancer; 2002 Feb; 96(1):53-7. PubMed ID: 11836704
[TBL] [Abstract][Full Text] [Related]
73. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections.
Fan Z; van de Rijn M; Montgomery K; Rouse RV
Mod Pathol; 2003 Feb; 16(2):137-44. PubMed ID: 12591966
[TBL] [Abstract][Full Text] [Related]
74. [Role of arginase-1 expression in distinguishing hepatocellular carcinoma from non-hepatocellular tumors].
Sang W; Gulinar A; Wang CH; Sheng WQ; Maiweilidan Y; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):538-42. PubMed ID: 24246920
[TBL] [Abstract][Full Text] [Related]
75. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.
Yan BC; Gong C; Song J; Krausz T; Tretiakova M; Hyjek E; Al-Ahmadie H; Alves V; Xiao SY; Anders RA; Hart JA
Am J Surg Pathol; 2010 Aug; 34(8):1147-54. PubMed ID: 20661013
[TBL] [Abstract][Full Text] [Related]
76. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma.
Lei JY; Huang J
Expert Opin Med Diagn; 2008 Feb; 2(2):151-9. PubMed ID: 23485135
[TBL] [Abstract][Full Text] [Related]
77. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma.
Varma V; Cohen C
Adv Anat Pathol; 2004 Sep; 11(5):239-49. PubMed ID: 15322490
[TBL] [Abstract][Full Text] [Related]
78. Gastric-Type Expression Signature in Hepatocellular Carcinoma.
Szodorai R; Banias L; Kovalszky I; Dezső K; Kovács Z; Gurzu S
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928294
[TBL] [Abstract][Full Text] [Related]
79. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors.
Wennerberg AE; Nalesnik MA; Coleman WB
Am J Pathol; 1993 Oct; 143(4):1050-4. PubMed ID: 7692729
[TBL] [Abstract][Full Text] [Related]
80. Melan A (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas.
Ghorab Z; Jorda M; Ganjei P; Nadji M
Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):330-3. PubMed ID: 14663359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
